Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Assets (2023 - 2025)

Mangoceuticals' Return on Assets history spans 3 years, with the latest figure at 1.06% for Q3 2025.

  • For Q3 2025, Return on Assets fell 44.0% year-over-year to 1.06%; the TTM value through Sep 2025 reached 1.06%, down 44.0%, while the annual FY2024 figure was 1.06%, N/A changed from the prior year.
  • Return on Assets for Q3 2025 was 1.06% at Mangoceuticals, down from 0.67% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.58% in Q4 2024 and bottomed at 13.34% in Q1 2024.
  • The 3-year median for Return on Assets is 0.86% (2025), against an average of 3.13%.
  • The largest YoY upside for Return on Assets was 1274bps in 2025 against a maximum downside of -44bps in 2025.
  • A 3-year view of Return on Assets shows it stood at 6.96% in 2023, then surged by 92bps to 0.58% in 2024, then tumbled by -84bps to 1.06% in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Return on Assets are 1.06% (Q3 2025), 0.67% (Q2 2025), and 0.6% (Q1 2025).